ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,458Medicare Part D Prescriptions Filled, Including Refills

Rank: 374 out of 2343

$642K Total Retail Price of All Prescriptions

Rank: 396 out of 2343

297 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 297 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 297 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 11,173 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 574 549 1 2
OMEPRAZOLE 555 555 2 4
FUROSEMIDE 417 417 3 6
DONEPEZIL HCL 398 398 4 21
CITALOPRAM HBR 378 378 5 17
NAMENDA 315 315 6 36
METOPROLOL TARTRATE 265 265 7 7
WARFARIN SODIUM 254 238 8 8
SIMVASTATIN 223 200 9 1
POLYETHYLENE GLYCOL 3350 219 214 10 54
MIRTAZAPINE 212 212 11 41
QUETIAPINE FUMARATE 204 204 12 77
FENTANYL 187 187 S2 13 69
POTASSIUM CHLORIDE 180 180 14 18
SPIRONOLACTONE 161 161 15 65
TRAZODONE HCL 157 157 16 53
GABAPENTIN 157 133 16 16
SERTRALINE HCL 157 157 16 20
AMLODIPINE BESYLATE 152 152 19 5
METOPROLOL SUCCINATE 145 145 20 14
HYDROCHLOROTHIAZIDE 145 145 20 11
RISPERIDONE 125 125 22 61
LISINOPRIL 121 109 23 3
METFORMIN HCL 120 120 24 9
ATENOLOL 109 109 25 12
TAMSULOSIN HCL 107 107 26 29
DIGOXIN 104 104 27 35
EXELON 90 90 28 129
ALBUTEROL SULFATE 89 89 29 126
JANUVIA 86 74 30 50
HALOPERIDOL 86 86 30 229
RAMIPRIL 83 83 32 90
RANITIDINE HCL 81 81 33 43
ZOSTAVAX 81 78 33 236
FAMOTIDINE 79 79 35 60
CARVEDILOL 77 77 36 27
BUDESONIDE 76 76 37 313
PRAVASTATIN SODIUM 76 76 37 15
BUSPIRONE HCL 75 63 39 146
SANTYL 71 66 40 195
OLANZAPINE 71 71 40 121
NATEGLINIDE 68 68 42 255
ESCITALOPRAM OXALATE 67 67 43 55
OXYCODONE-ACETAMINOPHEN 64 64 S2 44 49
HYDROCORTISONE 60 60 45 225
ZOLPIDEM TARTRATE 59 59 46 24
SPIRIVA 58 58 47 48
DIOVAN 57 57 48 23
TRAMADOL HCL 57 57 48 25
PLAVIX 57 57 48 38
CLOPIDOGREL 56 56 51 26
SEROQUEL 56 56 51 171
LOPERAMIDE 56 56 51 238
AZITHROMYCIN 55 55 54 39
PHENYTOIN SODIUM EXTENDED 54 54 55 152
ABILIFY 53 41 56 159
KETOCONAZOLE 52 52 57 232
PROCRIT 52 52 57 306
IPRATROPIUM-ALBUTEROL 51 51 59 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.